These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33911091)

  • 1. Extracellular vesicles derived from ascitic fluid enhance growth and migration of ovarian cancer cells.
    Mitra A; Yoshida-Court K; Solley TN; Mikkelson M; Yeung CLA; Nick A; Lu K; Klopp AH
    Sci Rep; 2021 Apr; 11(1):9149. PubMed ID: 33911091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologically Active Tissue Factor-Bearing Larger Ectosome-Like Extracellular Vesicles in Malignant Effusions from Ovarian Cancer Patients: Correlation with Incidence of Thrombosis.
    Steidel C; Ender F; Rody A; von Bubnoff N; Gieseler F
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33466775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of benign peritoneal fluid- and ovarian cancer ascites-derived extracellular vesicle RNA biomarkers.
    Yamamoto CM; Oakes ML; Murakami T; Muto MG; Berkowitz RS; Ng SW
    J Ovarian Res; 2018 Mar; 11(1):20. PubMed ID: 29499737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-18a-5p derived from mesenchymal stem cells-extracellular vesicles inhibits ovarian cancer cell proliferation, migration, invasion, and chemotherapy resistance.
    Wang X; Jiang L; Liu Q
    J Transl Med; 2022 Jun; 20(1):258. PubMed ID: 35672774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
    Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
    Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-106a-5p carried by tumor-derived extracellular vesicles promotes the invasion and metastasis of ovarian cancer by targeting KLF6.
    Zheng Y; Zhu K; Wang G
    Clin Exp Metastasis; 2022 Aug; 39(4):603-621. PubMed ID: 35449340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic analysis of ascitic extracellular vesicles describes tumour microenvironment and predicts patient survival in ovarian cancer.
    Vyhlídalová Kotrbová A; Gömöryová K; Mikulová A; Plešingerová H; Sladeček S; Kravec M; Hrachovinová Š; Potěšil D; Dunsmore G; Blériot C; Bied M; Kotouček J; Bednaříková M; Hausnerová J; Minář L; Crha I; Felsinger M; Zdráhal Z; Ginhoux F; Weinberger V; Bryja V; Pospíchalová V
    J Extracell Vesicles; 2024 Mar; 13(3):e12420. PubMed ID: 38490958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated analysis of ascites and plasma extracellular vesicles identifies a miRNA-based diagnostic signature in ovarian cancer.
    Wang W; Jo H; Park S; Kim H; Kim SI; Han Y; Lee J; Seol A; Kim J; Lee M; Lee C; Dhanasekaran DN; Ahn T; Song YS
    Cancer Lett; 2022 Aug; 542():215735. PubMed ID: 35569696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular vesicle-packaged miR-181c-5p from epithelial ovarian cancer cells promotes M2 polarization of tumor-associated macrophages via the KAT2B/HOXA10 axis.
    Yang S; Zhao H; Xiao W; Shao L; Zhao C; Sun P
    J Gene Med; 2022 Oct; 24(10):e3446. PubMed ID: 36027869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-derived small extracellular vesicles facilitate omental metastasis of ovarian cancer by triggering activation of mesenchymal stem cells.
    Gong L; Li G; Yi X; Han Q; Wu Q; Ying F; Shen L; Cao Y; Liu X; Gao L; Li W; Wang Z; Cai J
    Cell Commun Signal; 2024 Jan; 22(1):47. PubMed ID: 38233863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular vesicles derived from stored red blood cell suspensions enhance invasion and migration of lung cancer cells by miR1246 and miR150-3p.
    Cheng Z; Kong Y; Xu H; Xiao L; Tian L; Liu Z
    Vox Sang; 2024 Aug; 119(8):809-820. PubMed ID: 38839077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small extracellular vesicles from malignant ascites of patients with advanced ovarian cancer provide insights into the dynamics of the extracellular matrix.
    Bortot B; Apollonio M; Rampazzo E; Valle F; Brucale M; Ridolfi A; Ura B; Addobbati R; Di Lorenzo G; Romano F; Buonomo F; Ripepi C; Ricci G; Biffi S
    Mol Oncol; 2021 Dec; 15(12):3596-3614. PubMed ID: 34614287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ascitic fluid shear stress in concert with hepatocyte growth factor drive stemness and chemoresistance of ovarian cancer cells via the c-Met-PI3K/Akt-miR-199a-3p signaling pathway.
    Hassan AA; Artemenko M; Tang MKS; Shi Z; Chen LY; Lai HC; Yang Z; Shum HC; Wong AST
    Cell Death Dis; 2022 Jun; 13(6):537. PubMed ID: 35676254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of ovarian cancer ascites on cell invasion, proliferation, spheroid formation, and gene expression in an in vitro model of epithelial ovarian cancer.
    Puiffe ML; Le Page C; Filali-Mouhim A; Zietarska M; Ouellet V; Tonin PN; Chevrette M; Provencher DM; Mes-Masson AM
    Neoplasia; 2007 Oct; 9(10):820-9. PubMed ID: 17971902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular vesicles derived from M1 macrophages deliver miR-146a-5p and miR-146b-5p to suppress trophoblast migration and invasion by targeting TRAF6 in recurrent spontaneous abortion.
    Ding J; Zhang Y; Cai X; Zhang Y; Yan S; Wang J; Zhang S; Yin T; Yang C; Yang J
    Theranostics; 2021; 11(12):5813-5830. PubMed ID: 33897883
    [No Abstract]   [Full Text] [Related]  

  • 16. Breast cancer cell-derived extracellular vesicles transfer miR-182-5p and promote breast carcinogenesis via the CMTM7/EGFR/AKT axis.
    Lu C; Zhao Y; Wang J; Shi W; Dong F; Xin Y; Zhao X; Liu C
    Mol Med; 2021 Jul; 27(1):78. PubMed ID: 34294040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian cancer-derived ascitic fluids induce a senescence-dependent pro-cancerogenic phenotype in normal peritoneal mesothelial cells.
    Mikuła-Pietrasik J; Uruski P; Matuszkiewicz K; Szubert S; Moszyński R; Szpurek D; Sajdak S; Tykarski A; Książek K
    Cell Oncol (Dordr); 2016 Oct; 39(5):473-481. PubMed ID: 27444787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EV-associated miRNAs from peritoneal lavage as potential diagnostic biomarkers in colorectal cancer.
    Roman-Canal B; Tarragona J; Moiola CP; Gatius S; Bonnin S; Ruiz-Miró M; Sierra JE; Rufas M; González E; Porcel JM; Gil-Moreno A; Falcón-Pérez JM; Ponomarenko J; Matias-Guiu X; Colas E
    J Transl Med; 2019 Jun; 17(1):208. PubMed ID: 31221189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Methods for MicroRNA Isolation from Extracellular Vesicles Obtained from Ascitic Fluids.
    Skryabin GO; Vinokurova SV; Elkina NV; Denisova DA; Beliaeva AA; Zhordania KI; Bagrov DV; Enikeev AD; Galetsky SA; Komelkov AV; Krasnoshekova GI; Tchevkina EM
    Biochemistry (Mosc); 2022 Nov; 87(11):1354-1366. PubMed ID: 36509726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular vesicle-encapsulated microRNA-296-3p from cancer-associated fibroblasts promotes ovarian cancer development through regulation of the PTEN/AKT and SOCS6/STAT3 pathways.
    Sun L; Ke M; Yin M; Zeng Y; Ji Y; Hu Y; Fu S; Zhang C
    Cancer Sci; 2024 Jan; 115(1):155-169. PubMed ID: 37972389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.